Literature DB >> 30847549

A glycine transporter SLC6A5 frameshift mutation causes startle disease in Spanish greyhounds.

Sarah C Murphy1, Alfredo Recio2,3, Cristian de la Fuente2, Ling T Guo4, G Diane Shelton5, Leigh Anne Clark6.   

Abstract

Startle disease, or hyperekplexia, is a glycinergic disorder characterized by hypertonia and apnea that is triggered by noise and/or touch. Mutations in five genes have been associated with startle disease in humans, dogs, cattle, and mice. We identified a novel recessive startle disease in a family of Spanish greyhounds. Whole genome resequencing of an affected dog revealed a homozygous two base pair deletion in the ninth exon of SLC6A5, encoding the presynaptic glycine transporter. The deletion is predicted to cause a frameshift, p.S460FfsX47, leading to a premature stop codon that truncates over a third of the protein. Family members were genotyped for the deletion, and findings were consistent with an autosomal recessive inheritance pattern. The pathogenic variant was absent from 34 unrelated greyhounds, 659 domestic dogs of pure and mixed breeds, and 54 wild canids, suggesting it occurred recently and may be private to the family. The findings of this study can be used to inform future breeding decisions and prevent dissemination of the deleterious allele in greyhounds.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30847549     DOI: 10.1007/s00439-019-01986-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia.

Authors:  Mark I Rees; Kirsten Harvey; Hamish Ward; Julia H White; Luc Evans; Ian C Duguid; Cynthia C-H Hsu; Sharon L Coleman; Jan Miller; Kristin Baer; Henry J Waldvogel; Francis Gibbon; Trevor G Smart; Michael J Owen; Robert J Harvey; Russell G Snell
Journal:  J Biol Chem       Date:  2003-04-08       Impact factor: 5.157

2.  Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia.

Authors:  Volker Eulenburg; Kristina Becker; Jesús Gomeza; Bernhard Schmitt; Cord-Michael Becker; Heinrich Betz
Journal:  Biochem Biophys Res Commun       Date:  2006-07-26       Impact factor: 3.575

Review 3.  Myotonia and disorders of altered muscle cell membrane excitability.

Authors:  Charles H Vite
Journal:  Vet Clin North Am Small Anim Pract       Date:  2002-01       Impact factor: 2.093

4.  Hyperekplexia associated with compound heterozygote mutations in the beta-subunit of the human inhibitory glycine receptor (GLRB).

Authors:  Mark I Rees; Trevor M Lewis; John B J Kwok; Geert R Mortier; Paul Govaert; Russell G Snell; Peter R Schofield; Michael J Owen
Journal:  Hum Mol Genet       Date:  2002-04-01       Impact factor: 6.150

Review 5.  Startle syndromes.

Authors:  Mirte J Bakker; J Gert van Dijk; Arn M J M van den Maagdenberg; Marina A J Tijssen
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

6.  Highly effective SNP-based association mapping and management of recessive defects in livestock.

Authors:  Carole Charlier; Wouter Coppieters; Frédéric Rollin; Daniel Desmecht; Jorgen S Agerholm; Nadine Cambisano; Eloisa Carta; Sabrina Dardano; Marc Dive; Corinne Fasquelle; Jean-Claude Frennet; Roger Hanset; Xavier Hubin; Claus Jorgensen; Latifa Karim; Matthew Kent; Kirsten Harvey; Brian R Pearce; Patricia Simon; Nico Tama; Haisheng Nie; Sébastien Vandeputte; Sigbjorn Lien; Maria Longeri; Merete Fredholm; Robert J Harvey; Michel Georges
Journal:  Nat Genet       Date:  2008-03-16       Impact factor: 38.330

Review 7.  The genetics of hyperekplexia: more than startle!

Authors:  Robert J Harvey; Maya Topf; Kirsten Harvey; Mark I Rees
Journal:  Trends Genet       Date:  2008-08-15       Impact factor: 11.639

8.  The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering.

Authors:  Kirsten Harvey; Ian C Duguid; Melissa J Alldred; Sarah E Beatty; Hamish Ward; Nicholas H Keep; Sue E Lingenfelter; Brian R Pearce; Johan Lundgren; Michael J Owen; Trevor G Smart; Bernhard Lüscher; Mark I Rees; Robert J Harvey
Journal:  J Neurosci       Date:  2004-06-23       Impact factor: 6.167

9.  Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality.

Authors:  Jesús Gomeza; Koji Ohno; Swen Hülsmann; Wencke Armsen; Volker Eulenburg; Diethelm W Richter; Bodo Laube; Heinrich Betz
Journal:  Neuron       Date:  2003-11-13       Impact factor: 17.173

10.  Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.

Authors:  Mark I Rees; Kirsten Harvey; Brian R Pearce; Seo-Kyung Chung; Ian C Duguid; Philip Thomas; Sarah Beatty; Gail E Graham; Linlea Armstrong; Rita Shiang; Kim J Abbott; Sameer M Zuberi; John B P Stephenson; Michael J Owen; Marina A J Tijssen; Arn M J M van den Maagdenberg; Trevor G Smart; Stéphane Supplisson; Robert J Harvey
Journal:  Nat Genet       Date:  2006-06-04       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.